TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Entheon Biomedical ( (TSE:ENBI) ) just unveiled an announcement.
Entheon Biomedical Corp. announced the termination of its agreement with Mentis AI, which involved acquiring all common shares of the latter. This development may impact Entheon’s strategic plans in the biotechnology sector, particularly in its focus on addiction treatment, and could have implications for stakeholders involved in the proposed acquisition.
More about Entheon Biomedical
Entheon Biomedical Corp. is a biotechnology research and development company focused on treating addiction and substance use disorders.
YTD Price Performance: -53.57%
Average Trading Volume: 3,038
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $1.73M
Find detailed analytics on ENBI stock on TipRanks’ Stock Analysis page.